NYC’s Leading Integrative Health Care Center
NYC’s Leading Integrative Health Care Center
Medically reviewed by Rashmi Gulati, MD — Last updated: August 6, 2026
Gynecologists specialize in women’s reproductive health, including menstrual concerns, hormonal changes, pelvic conditions, and reproductive wellness. Regular gynecological care can support prevention, diagnosis, and treatment.
Irregular cycles, unexplained weight gain, pelvic pain, and stubborn acne are rarely isolated problems — they are usually signals from a disrupted hypothalamic-pituitary-ovarian axis. At Patients Medical, our NYC physicians investigate the hormonal pattern behind your symptoms with in-depth testing, rather than defaulting to a birth control prescription that mutes them.
women affected by endometriosis in their reproductive years
of reproductive-age women have PCOS
of PCOS cases go undiagnosed
typical timeline to hormonal recalibration
Board-certified integrative medicine physician.
Gynecological health disorders are hormonal and structural imbalances of the female reproductive system, most often rooted in disrupted hypothalamic-pituitary-ovarian signaling, insulin resistance, or impaired estrogen metabolism, that manifest as irregular cycles, pelvic pain, and metabolic symptoms.
A gynecological hormonal imbalance occurs when the signaling between the brain and the ovaries, known as the hypothalamic-pituitary-ovarian (HPO) axis, no longer produces a regular, predictable pattern of estrogen and progesterone across the menstrual cycle. In a typical 28-day cycle, estrogen rises to trigger ovulation, then progesterone rises to prepare the uterine lining; when either hormone is produced too much, too little, or at the wrong time, the cycle becomes irregular and symptoms follow.
Mechanistically, the most common driver we see clinically is insulin resistance, in which cells stop responding efficiently to insulin, forcing the pancreas to produce more of it. Excess insulin stimulates the ovaries to produce more testosterone and interferes with the pituitary’s release of follicle-stimulating hormone, which is the pattern underlying polycystic ovary syndrome (PCOS). A second common driver is impaired estrogen metabolism in the liver, which allows estrogen to recirculate rather than being cleared, producing a state of relative estrogen dominance even when absolute estrogen levels look “normal” on a standard blood test.
Conventional gynecology recognizes these mechanisms but often treats the resulting symptom, prescribing hormonal contraceptives to regulate bleeding or spironolactone for acne, without necessarily investigating why the underlying signaling broke down. Functional medicine considers this an incomplete answer: contraceptives can effectively manage symptoms for many patients, but they do not correct insulin resistance, thyroid dysfunction, or estrogen clearance problems, which is why symptoms frequently return once medication stops.
These imbalances are common. Polycystic ovary syndrome alone affects between 8 and 13 percent of women of reproductive age, and endometriosis affects roughly 1 in 10, making gynecological hormonal imbalance one of the most frequent reasons women in their 20s through 40s seek care, though it is also frequently under-recognized because symptoms are dismissed as “normal” period problems.
The hormonal communication loop between the brain and ovaries that governs ovulation timing. Chronic stress and blood sugar instability disrupt this signaling first.
Fluid-filled sacs that mature and release an egg each cycle. In PCOS, elevated androgens prevent follicles from maturing fully, leaving them visible as small cysts on ultrasound.
The uterine lining that thickens under estrogen and progesterone influence. Imbalance here drives heavy bleeding, while endometrial-like tissue outside the uterus underlies endometriosis.
Because estrogen, progesterone, and testosterone receptors exist throughout the body, hormonal imbalance rarely stays confined to the reproductive system alone — it shows up across energy, mood, metabolism, and skin as well as the menstrual cycle itself.
Signals anovulation, most often from PCOS or thyroid dysfunction.
Reflects excess estrogen relative to progesterone thickening the endometrium.
Driven by prostaglandin release and, in some cases, endometrial tissue outside the uterus.
Associated with endometriosis or vaginal estrogen deficiency.
Can reflect an abrupt estrogen dip around ovulation.
Insulin resistance promotes abdominal fat storage independent of caloric intake.
Classic pattern of androgen-driven sebum production.
Reflects elevated free testosterone acting on hair follicles.
Androgen-sensitive scalp follicles miniaturize under excess testosterone.
Often compounded by coexisting thyroid dysfunction or adrenal dysregulation.
Linked to the sharp progesterone drop before menstruation.
Progesterone's metabolite allopregnanolone normally calms GABA receptors; low progesterone removes this buffer.
Estrogen supports hippocampal function, so fluctuating levels can blunt memory and focus.
Often coexists with the fatigue of undiagnosed thyroid dysfunction.
Falling progesterone reduces its sedative metabolite.
Irregular ovulation is one of the leading causes of female infertility.
Can reflect insufficient luteal-phase progesterone.
Reflects declining estrogen, whether from perimenopause or hypothalamic suppression.
Hormonal shifts alter vaginal pH and glycogen availability.
Commonly reflects estrogen dominance relative to progesterone.
Gynecological hormonal imbalance does not follow a single staging system the way a cancer or an infection might; instead, risk clusters around specific life stages, metabolic profiles, and family history, which is why we assess each patient’s individual risk pattern rather than applying a one-size-fits-all timeline.
Cycles are often irregular in the first 2–3 years after menarche as the HPO axis matures; persistent irregularity beyond this window, especially with acne or weight changes, warrants evaluation for early PCOS.
The peak window for PCOS and endometriosis diagnosis, often triggered by a fertility evaluation after months of unsuccessful attempts to conceive.
Progesterone typically declines before estrogen, producing a relative estrogen-dominant state with heavier bleeding, worsening PMS, and new-onset migraines.
A first-degree relative with PCOS, pre-existing insulin resistance, obesity, or a thyroid autoimmune condition substantially raises individual risk.
Most patients we see do not have a single trigger; instead, two or three of the following mechanisms interact and reinforce each other, which is why treating only one, such as prescribing a contraceptive without addressing insulin resistance, often produces incomplete relief.
Elevated insulin drives ovarian androgen production and disrupts ovulation.
Cortisol competes with progesterone for the same precursor, pregnenolone.
Both hypo- and hyperthyroidism disrupt cycle regularity and ovulation.
Sluggish liver methylation pathways allow estrogen to recirculate.
Inflammatory cytokines interfere with follicular development.
BPA, phthalates, and parabens can mimic or block estrogen receptors.
PCOS shows a strong familial pattern, particularly through maternal lineage.
Low vitamin D, magnesium, or B6 impair hormone synthesis and clearance.
Adipose tissue independently produces estrogen, compounding existing imbalance.
The “estrobolome,” gut bacteria that metabolize estrogen, affects how much is recirculated.
Poor sleep elevates cortisol and worsens insulin sensitivity.
Natural reduction in progesterone-producing follicles with age.
Several conditions share overlapping symptoms with general hormonal imbalance, which is why an accurate diagnosis depends on comparing biomarker patterns rather than symptoms alone.
| Features | PCOS | Endometriosis | Hypothyroidism | Perimenopause |
|---|---|---|---|---|
| Key biomarker | Elevated testosterone/DHEA-S, elevated LH:FSH ratio | No definitive blood biomarker | Elevated TSH, low free T4 | Fluctuating, then declining estradiol |
| Best diagnostic test | Hormone panel + pelvic ultrasound | Laparoscopy (definitive); ultrasound suggestive | Thyroid panel with antibodies | Cycle history + hormone panel |
| Hallmark symptom | Infrequent periods, acne, weight gain | Severe cyclical pelvic pain | Fatigue, cold intolerance, weight gain | Irregular cycles, hot flashes, sleep changes |
| Standard blood test detection | Often missed without ultrasound | Not detectable by blood test | Reliably detected | Partially detected; timing-dependent |
| Treatment approach | Insulin-sensitizing agents, inositol, diet | Anti-inflammatory support, hormonal therapy, surgery | Thyroid hormone optimization | Bioidentical hormone support |
| Overlap | All four can coexist and compound one another, particularly PCOS and hypothyroidism | |||
The most clinically important overlap we see is between PCOS and hypothyroidism: both cause irregular cycles and weight gain, and treating one without screening for the other frequently leaves patients only partially improved.
Our position: We do not present functional testing as a replacement for conventional gynecologic care — we consider it a valuable complement. Some patients need surgical or pharmaceutical intervention regardless of root-cause work, and we coordinate with OB-GYNs when that is the case. Our goal is a more complete picture, not a rejection of conventional medicine.
Measures estradiol, progesterone, total and free testosterone, and DHEA-S, timed to specific cycle days. This reveals the estrogen-to-progesterone ratio that a single random-day draw misses entirely.
Captures hormone metabolites over 24 hours, showing not just how much estrogen and cortisol the body produces but how efficiently it clears them — detail standard blood panels cannot provide.
Includes TSH, free T3, free T4, and thyroid peroxidase antibodies, since subclinical thyroid dysfunction frequently masquerades as or worsens gynecological symptoms.
Screens for the insulin resistance that drives most PCOS cases, often abnormal years before fasting glucose alone would flag a problem.
Assesses ovarian follicle pattern and rules out structural causes such as fibroids or cysts that can produce similar bleeding and pain symptoms.
Check all that apply to your current experience:
Every treatment plan is built from an individual patient’s hormone, thyroid, and metabolic testing rather than a standardized protocol, because a patient with insulin-resistant PCOS and a patient with perimenopausal progesterone decline need fundamentally different interventions.
Restores physiologic progesterone or estrogen levels using hormones structurally identical to what the body produces, dosed and monitored through repeat lab testing.
Evidence-guided supplementation selected from DUTCH and hormone panel results, not a generic “hormone balance” stack.
Delivers nutrients directly for patients with absorption issues or significant deficiencies identified on testing, supporting hormone synthesis pathways.
Structured, blood-sugar-focused nutrition planning to reverse the insulin resistance driving most PCOS-pattern imbalances.
Addresses the cortisol-progesterone competition for shared precursor hormones that worsens luteal phase symptoms.
Coordinated ovulation-support planning built from hormone testing before proceeding to assisted reproductive technology.
Weeks 2–4: initial mood and energy shifts as targeted supplementation begins. Weeks 6–8: cycle regularity and symptom intensity typically start improving. Months 3–6: repeat hormone and metabolic panels confirm biochemical correction, not just symptom relief, with dosing adjusted accordingly.
Take your temperature immediately upon waking, before getting out of bed, using a basal thermometer. A sustained rise of 0.5–1°F after ovulation confirms progesterone production; a flat pattern suggests anovulation worth discussing with your physician.
Resistance training improves insulin sensitivity more effectively than cardio alone for PCOS-pattern imbalance. Aim for compound movements — squats, deadlifts, presses — at a challenging weight for 8–12 reps.
Go to bed and wake at the same time daily, even on weekends, to stabilize cortisol rhythm. Cortisol dysregulation directly competes with progesterone production for the same precursor hormone.
Spend 10 minutes daily on slow diaphragmatic breathing — 4 seconds in, 7 seconds hold, 8 seconds out — to lower cortisol and support the nervous system input the ovaries rely on for regular signaling.
Switch to glass or stainless-steel food storage, avoid microwaving in plastic, and choose fragrance-free personal care products to reduce cumulative BPA and phthalate exposure linked to estrogen disruption.
Stop screen use 60–90 minutes before bed, or use blue-light-blocking glasses, since evening light exposure suppresses melatonin, which in turn affects the downstream hormone cascade governing ovulation.
Blood sugar stability is the single most important dietary lever for gynecological hormone balance, because insulin spikes directly stimulate ovarian androgen production and disrupt the signaling that governs regular ovulation.
Pair every carbohydrate with protein or fat, and avoid eating carbohydrates alone on an empty stomach, to blunt the insulin spike that drives androgen excess.
Gynecological hormonal imbalance rarely occurs in isolation; the following conditions are commonly comorbid and frequently share overlapping root causes.
The most common driver of anovulatory cycles, sharing the insulin-resistance mechanism at the core of many gynecological presentations.
An inflammatory condition frequently coexisting with hormonal imbalance, sharing the symptom of severe cyclical pelvic pain.
Thyroid dysfunction independently disrupts ovulation and is commonly found alongside gynecological hormone imbalance.
Reflects the mood and physical symptoms of the luteal-phase progesterone decline central to many hormone imbalance presentations.
Often the presenting concern that leads to a hormonal imbalance diagnosis after months of irregular ovulation.
Represents the natural endpoint of ovarian hormone decline, sharing many symptoms with perimenopausal hormone imbalance.
Many gynecological symptoms are dismissed as a normal part of having a menstrual cycle, but persistent or worsening symptoms deserve a thorough evaluation rather than being managed indefinitely with over-the-counter pain relief alone.
🚨 Seek immediate emergency medical evaluation if you experience: sudden, severe pelvic pain with fever, heavy bleeding that soaks through more than one pad per hour for several consecutive hours, fainting or lightheadedness with bleeding, or pain accompanied by a positive pregnancy test, as these can indicate a medical emergency requiring urgent in-person care.
Individual results vary. Testimonials reflect personal patient experiences and are not a guarantee of outcomes.
Yes. Hormonal imbalance affecting the female reproductive system is a well-recognized clinical reality, though it is often under-diagnosed because standard testing only checks whether hormone levels fall within a broad reference range, not whether they are optimal for an individual patient. Conditions like PCOS, estrogen dominance, and luteal phase deficiency are documented in medical literature and directly affect ovulation, menstrual regularity, mood, and metabolic health. Conventional gynecology tends to treat the resulting symptoms with hormonal contraceptives that suppress the cycle rather than identifying why the imbalance developed. Functional medicine treats the imbalance itself as the diagnosis, using comprehensive hormone panels, including DUTCH testing, to map the pattern of estrogen, progesterone, testosterone, and cortisol across the cycle. Patients who have been told their labs are “normal” while still experiencing significant symptoms are often being tested with an insufficiently detailed panel, not imagining the problem.
Most patients notice initial improvements in cycle regularity, energy, and mood within 4 to 8 weeks, though full hormonal recalibration typically takes 3 to 6 months. The timeline depends on which systems are involved: adjusting bioidentical progesterone for a short luteal phase can improve symptoms relatively quickly, while reversing insulin-resistance-driven PCOS or long-standing estrogen dominance takes longer because it requires rebuilding metabolic function, not just supplementing a hormone. We typically re-test hormone panels at 90-day intervals to confirm the protocol is working biochemically, not only symptomatically. Diet and lifestyle changes, particularly blood sugar stabilization and stress reduction, accelerate the timeline meaningfully. We set expectations at the first visit based on each patient’s specific hormone pattern and history, since a 22-year-old with new-onset irregular cycles and a 44-year-old in perimenopause typically follow very different timelines.
Diagnosis starts with a comprehensive hormone panel measuring estradiol, progesterone, total and free testosterone, DHEA-S, and cortisol, ideally timed to specific days of the menstrual cycle rather than a single random draw. We frequently add DUTCH testing, which measures hormone metabolites in dried urine over 24 hours and reveals how efficiently the body is metabolizing and clearing hormones like estrogen and cortisol. A thyroid panel, including TSH, free T3, free T4, and thyroid antibodies, is standard, because thyroid dysfunction frequently mimics or worsens gynecological symptoms. Pelvic ultrasound assesses ovarian structure and can identify the follicle pattern associated with PCOS or detect fibroids and cysts. Fasting insulin and glucose testing screens for the insulin resistance that drives many cases of PCOS. Together, these tests build a physiological picture rather than a single data point.
Yes, and it is one of the most common reasons patients seek an evaluation. Elevated androgens and insulin resistance, the hallmark pattern in PCOS, directly promote fat storage around the abdomen and make weight loss disproportionately difficult regardless of diet and exercise effort. Estrogen dominance relative to progesterone can also drive fluid retention and fat storage in the hips and thighs, while low progesterone in the luteal phase is linked to increased appetite and carbohydrate cravings. Thyroid dysfunction, which frequently coexists with gynecological hormone imbalances, slows metabolic rate independently. Because these mechanisms are metabolic and hormonal rather than purely behavioral, standard calorie-restriction advice often fails these patients. Correcting the underlying insulin resistance, rebalancing the estrogen-to-progesterone ratio, and supporting thyroid function typically must happen before sustainable weight change becomes possible.
PCOS and endometriosis are both common gynecological conditions that cause irregular cycles and fertility difficulty, but they involve different mechanisms and require different testing. PCOS is primarily a metabolic and ovulatory disorder driven by insulin resistance and elevated androgens, diagnosed through irregular cycles, elevated testosterone or DHEA-S, and a characteristic follicle pattern on ultrasound. Endometriosis is an inflammatory condition in which endometrial-like tissue grows outside the uterus, causing significant pelvic pain, often worst around menstruation, and is definitively diagnosed only through laparoscopic surgery. PCOS more often presents with infrequent or absent periods, acne, and midsection weight gain, while endometriosis is more strongly associated with severe menstrual pain, pain during intercourse, and cyclical gastrointestinal symptoms. It’s possible to have features of both simultaneously, which is why a thorough symptom history alongside hormone and imaging testing is essential.
Fertility depends on regular ovulation and an endometrial lining adequately prepared by progesterone, both of which are disrupted by common gynecological hormone imbalances. In PCOS, elevated androgens and insulin resistance interfere with brain-ovary signaling, causing irregular or absent ovulation, one of the leading causes of female infertility. A short luteal phase, where progesterone falls prematurely after ovulation, doesn’t allow the uterine lining enough time to support implantation, which can cause early pregnancy loss even when conception occurs. Estrogen dominance can thicken the endometrial lining abnormally and disrupt the feedback loop that triggers ovulation. Thyroid dysfunction is independently associated with ovulatory irregularity and increased miscarriage risk. Our fertility support protocols begin with comprehensive hormone and thyroid testing rather than proceeding directly to assisted reproductive technology, since correcting an underlying imbalance sometimes restores fertility on its own.
Supplement selection depends entirely on which hormonal pattern testing reveals, since the wrong supplement can worsen symptoms. Myo-inositol, typically combined with D-chiro-inositol in a 40:1 ratio, has strong clinical evidence for improving insulin sensitivity and restoring ovulation in PCOS. Magnesium glycinate supports progesterone production and reduces premenstrual cramping and irritability. DIM supports healthier estrogen metabolism in patients showing an unfavorable metabolite pattern on DUTCH testing. Vitamin D, a hormone precursor, is frequently deficient in patients with irregular cycles and is corrected based on measured blood levels. Omega-3 fatty acids reduce the inflammatory component of pelvic pain seen in endometriosis. We don’t recommend a generic supplement stack; every protocol is built from the individual patient’s DUTCH, hormone panel, and thyroid results, with dosing adjusted at follow-up.
Our physicians combine comprehensive hormone testing with a root-cause treatment plan built around your specific pattern, not a one-size-fits-all prescription. Let’s find out what your body has been trying to tell you.
Call us at (212) 794-8800 · 800 Second Avenue, Suite 900, New York, NY 10017
Patients Medical specializes in gently helping the patient identify the root cause of their medical issues and then assist them to recover from their problems to help them move forward to good health.
To schedule an in person on Tele-medicine appointment, please call our office at (212) 794-8800 or email us at info@PatientsMedical.com We look forward to hearing from you
Patients Medical PC
1148 Fifth Avenue, Suite 1B New York, NY 10128
Copyright © 2026 Patients Medical. All Rights Reserved.
All information presented in this website is intended for informational purposes only and not for the purpose of rendering medical advice. Statements made on this website have not been evaluated by the Food and Drug Administration. The information contained herein is not intended to diagnose, treat, cure or prevent any disease. Patients Medical.
Disclaimer: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE AND MAY BE OUT OF DATE. The information, including but not limited to text, PDFs, graphics, images, and other material contained on this website, is for general educational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment, and does not create a patient-doctor relationship. Pricing on the website may be out of date, is subject to change without notice, and may be subject to additional terms and conditions. No information on this site is intended to be a financial quote for medical services. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition, lifestyle or dietary changes, treatments, and before undertaking a new healthcare regimen. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
